Health & Wellness Investment Report: Q4 2022
Although 2022 was clearly a year of “normalization” after the extremely robust pandemic years of 2020 and 2021, investors began regrouping and planning their strategies for 2023 in Q4 of 2022. This included pre- and post- acquisition strategies as health and wellness, and private equity, companies focused on specialty and niche deals to address strategic needs and gaps to remain competitive.
In our Health & Wellness Q4 Investment Report, we detail:
- Market factors impacting the deal space
- Trending numbers
- Pre- and post-acquisition strategies
This has been prepared for information purposes and general guidance only and does not constitute legal or professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is made as to the accuracy or completeness of the information contained in this publication, and CohnReznick LLP, and their respective partners, members, employees and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it. CohnReznick LLP and our affiliated entities operating under the CohnReznick brand are separate legal entities that are independently operated.